Advertisement


Andrew D. Zelenetz, MD, on CLL: Emerging Treatments

2016 ASH Annual Meeting & Exposition
Tweet this page

Andrew D. Zelenetz, MD, of the Memorial Sloan Kettering Cancer Center, discusses novel treatments for chronic lymphocytic leukemia, touching specifically on the Gilead 115 trial.

Advertisement

Advertisement



Advertisement

click me